Compare Arwana Citramulia Tbk (ARNA) vs Prodia Diagnostic Line Tbk (PRDL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Arwana Citramulia Tbk vs Prodia Diagnostic Line Tbk — how do they compare? Arwana Citramulia Tbk trades at Rp498 (market cap 3.66T), while Prodia Diagnostic Line Tbk trades at Rp270 (market cap 470.58B). The key difference: Arwana Citramulia Tbk is far larger — about 7.8× Prodia Diagnostic Line Tbk's market cap. Which is the better fit depends on your goals.
| ARNA | PRDL | |
|---|---|---|
Market Cap | 3.66T | 470.58B |
Indicative Equilibrium Price | 500 | 270 |
Indicative Equilibrium Volume | 3 | 219 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Arwana Citramulia Tbk
PT. Arwana Citramulia Tbk (the Company) was established under the name PT Arwana Citra Mulia based on the notarial deed No. 21 dated February 22, 1993 of Raden Santoso, as amended by notarial deeds No. 147 dated October 26, 1993 and No. 105 dated November 15, 1993 of Imam Santoso, S.H., which covered, among others, the change in the Company's name PT Arwana Citramulia.
Read more on ARNA →About Prodia Diagnostic Line Tbk
PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →
